Lucosky Brookman LLP Successfully Represents Brüush Oral Care, Inc. in $15.5 Million Initial Public Offering
Lucosky Brookman congratulates its client, Brüush Oral Carel, Inc. (Nasdaq:BRSH) (the “Company”), on the pricing of its initial public offering of 3,728,549 units at a combined public offering price of $4.16 per unit, each consisting of one share of common stock and one warrant to purchase one share of common stock, with an initial exercise price of $4.16 per share. The gross proceeds of the offering are expected to be $15.5 million before deducting underwriting fees and other estimated offering expenses. The offering is expected to close on or about August 5, 2022, subject to customary closing conditions. In addition, the Company has granted Aegis Capital Corp. (“Aegis”) a 45-day option to purchase additional shares of common stock and/or warrants of up to 15% of the number of shares and warrants, respectively, sold in the offering solely to cover over-allotments, if any.
The Company also announced that, in connection with the offering, its common stock and warrants have been approved for listing on the Nasdaq Capital Market and will begin trading on the Nasdaq Capital Market under the symbol “BRSH” and “BRSHW”, respectively, on August 3, 2022.
Lucosky Brookman LLP acted as counsel to the Company. Aegis Capital Corp. acted as the sole book-running manager for the offering.